Literature DB >> 11884574

Mapping of genes involved in murine herpes simplex virus keratitis: identification of genes and their modifiers.

Kazumi Norose1, Akihiko Yano, Xiang-Ming Zhang, Elizabeth Blankenhorn, Ellen Heber-Katz.   

Abstract

Herpes simplex keratitis (HSK) is an inflammatory response to viral infection and self antigens in the cornea and is a major cause of blindness. Using two strains of mice which are susceptible (129/SVEV) and resistant (C57BL/6) to herpes simplex virus (HSV) strain KOS, (129/SVEV x C57BL/6)F(2) mice were generated and examined for their disease susceptibility in terms of clinical symptoms, ocular disease, and antibody production following corneal scarification with HSV (KOS). A genome-wide screen was carried out using microsatellite markers to determine the genetic loci involved in this response. Loci on chromosomes 4, 5, 12, 13, and 14 were shown to be involved in general susceptibility to clinical disease, whereas loci on chromosomes 10 and 17 were shown to be unique to ocular disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884574      PMCID: PMC136007          DOI: 10.1128/jvi.76.7.3502-3510.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP.

Authors:  M Ahmad; S M Srinivasula; L Wang; R V Talanian; G Litwack; T Fernandes-Alnemri; E S Alnemri
Journal:  Cancer Res       Date:  1997-02-15       Impact factor: 12.701

2.  An immunologist's view of herpes simplex keratitis: Thygeson Lecture 1996, presented at the Ocular Microbiology and Immunology Group meeting, October 26, 1996.

Authors:  R L Hendricks
Journal:  Cornea       Date:  1997-09       Impact factor: 2.651

Review 3.  Immunity causing blindness: five different paths to herpes stromal keratitis.

Authors:  J W Streilein; M R Dana; B R Ksander
Journal:  Immunol Today       Date:  1997-09

4.  An immunogenetic analysis of resistance to herpes simplex virus retinitis in inbred strains of mice.

Authors:  J S Pepose; J A Whittum-Hudson
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-09       Impact factor: 4.799

5.  Genetic studies on murine susceptibility to herpes simplex keratitis.

Authors:  C S Foster; Y Tsai; J G Monroe; R Campbell; M Cestari; R Wetzig; D Knipe; M I Greene
Journal:  Clin Immunol Immunopathol       Date:  1986-08

6.  Moderation of herpetic stromal keratitis by basic fibroblast growth factor.

Authors:  D Gamus; A Romano; M Rubinstein; N Savion
Journal:  Exp Eye Res       Date:  1996-07       Impact factor: 3.467

7.  Patterns of herpes simplex keratitis in inbred mice.

Authors:  R D Stulting; J C Kindle; A J Nahmias
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-10       Impact factor: 4.799

8.  Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  R W Melvold; D M Jokinen; S D Miller; M C Dal Canto; H L Lipton
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  Evidence that Tmevd2 and eae3 may represent either a common locus or members of a gene complex controlling susceptibility to immunologically mediated demyelination in mice.

Authors:  C Teuscher; D M Rhein; K D Livingstone; R A Paynter; R W Doerge; S M Nicholson; R W Melvold
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

10.  Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region.

Authors:  M Rodriguez; J Leibowitz; C S David
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  8 in total

1.  Mapping Murine Corneal Neovascularization and Weight Loss Virulence Determinants in the Herpes Simplex Virus 1 Genome and the Detection of an Epistatic Interaction between the UL and IRS/US Regions.

Authors:  Kyubin Lee; Aaron W Kolb; Inna Larsen; Mark Craven; Curtis R Brandt
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

2.  Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors.

Authors:  Gary D Luker; Julie L Prior; Jiling Song; Christina M Pica; David A Leib
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

3.  Re-evaluating natural resistance to herpes simplex virus type 1.

Authors:  William P Halford; John W Balliet; Bryan M Gebhardt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  A forward phenotypically driven unbiased genetic analysis of host genes that moderate herpes simplex virus virulence and stromal keratitis in mice.

Authors:  Richard L Thompson; Robert W Williams; Malak Kotb; Nancy M Sawtell
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

5.  Quantitative Trait Locus Based Virulence Determinant Mapping of the HSV-1 Genome in Murine Ocular Infection: Genes Involved in Viral Regulatory and Innate Immune Networks Contribute to Virulence.

Authors:  Aaron W Kolb; Kyubin Lee; Inna Larsen; Mark Craven; Curtis R Brandt
Journal:  PLoS Pathog       Date:  2016-03-10       Impact factor: 6.823

Review 6.  Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies.

Authors:  Vaibhav Tiwari; Morgan S Tarbutton; Deepak Shukla
Journal:  Molecules       Date:  2015-02-05       Impact factor: 4.411

7.  Characterization of Sex Differences in Ocular Herpes Simplex Virus 1 Infection and Herpes Stromal Keratitis Pathogenesis of Wild-Type and Herpesvirus Entry Mediator Knockout Mice.

Authors:  Rachel E Riccio; Seo J Park; Richard Longnecker; Sarah J Kopp
Journal:  mSphere       Date:  2019-03-27       Impact factor: 4.389

8.  TRPC1 participates in the HSV-1 infection process by facilitating viral entry.

Authors:  DongXu He; AiQin Mao; YouRan Li; SiuCheung Tam; YongTang Zheng; XiaoQiang Yao; Lutz Birnbaumer; Indu S Ambudkar; Xin Ma
Journal:  Sci Adv       Date:  2020-03-18       Impact factor: 14.136

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.